January 2018 FDA Recall Oxycodone Hydrochloride by Ascent Pharmaceuticals, Inc.
D-0248-2018 - Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol

This Class III drug recall was voluntarily initiated by Ascent Pharmaceuticals, Inc. on January 22, 2018 for the product Oxycodone Hydrochloride. The FDA reported the reason for recall as labeling; label error not elsewhere classified; label missing controlled substance cii symbol. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0248-2018

Reason for Recall
Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
Initiated
01-22-2018
Reported
02-07-2018
Quantity
45,875 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Ascent Pharmaceuticals, Inc.
Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01

Batch or Lot Expiration Information

Lot# Lot Numbers: 17080591 and 17080619, exp 07/19; 17110907 and 17110908, exp 10/19; and 17120986, exp 11/19